Hematopoietic Stem Cell Transplantation for Severe Combined Immune Deficiency or What the Children have Taught Us

Hematology/Oncology Clinics of North America

Volumn 25, Issue 1, 2011, Pages 17-30

  Rappeport, Joel M ^a   O'Reilly, Richard J ^b   Kapoor, Neena ^c,d   Parkman, Robertson ^c,d  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Gene transfer; Hematopoietic stem cell transplantation; In utero; Severe combined immune deficiency; Unrelated

Indexed keywords

HLA ANTIGEN; INTERLEUKIN 10;

ADRENOLEUKODYSTROPHY; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALPHA THALASSEMIA; ANTIGEN SPECIFICITY; APLASTIC ANEMIA; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BETA THALASSEMIA; BONE MARROW APLASIA; BONE MARROW DEPRESSION; CHIMERA; CLINICAL TRIAL (TOPIC); DNA VIRUS INFECTION; FETUS CELL; GENE TRANSFER; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HUMAN; HURLER SYNDROME; IN UTERO STEM CELL TRANSPLANTATION; LIVER CELL; LIVING DONOR; LYMPHOCYTE FUNCTION; NONHUMAN; PAPILLOMA VIRUS; PATIENT SAFETY; PRIORITY JOURNAL; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY; T CELL DEPLETION; TREATMENT DURATION;

EID: 78651077597     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2010.11.002     Document Type: Review

References (43)

1. Gatti R.A., Meeuwissen H.J., Allen H.D., et al. Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 1968, 2:1366-1369.
2. Copenhagen Study Group of Immunodeficiencies Bone-marrow transplantation from an HLA-A-nonidentical but mixed-lymphocyte-culture identical donor. Lancet 1973, 2:1146-1150.
3. O'Reilly R.J., Dupont B., Pahwa D., et al. Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor. N Engl J Med 1977, 297:1311-1318.
4. Reisner Y., Kapoor N., Kirkpatrick D., et al. Transplantation for SCID with HLA-1, B, D/DR incompatible marrow fractionated by soy bean agglutinin and sheep red blood cells. Blood 1983, 61:341-348.
5. Bordignon C., Notarangelo L.D., Nobili N., et al. Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science 1995, 270:470-474.
6. Ford C.E., Hamerton J.L., Barnes D.W.H., et al. Cytological identification of radiation chimaeras. Nature 1956, 177:452-454.
7. Jammet H., Mathé G., Pendic B., et al. Etude de six cas d'irradiation totale aiguë accidentelle [Study of six cases of accidental total body irradiation]. Rev Fr Etud Clin Biol 1959, 4:210-225. [in French].
8. Meuwissen H.J., Gatti R.A., Terasaki P.I., et al. Treatment of lymphopenic hypogammaglobulinemia and bone-marrow aplasia by transplantation of allogenic marrow. Crucial role of histocompatibility matching. N Engl J Med 1969, 281:691-697.
9. Park B.H., Biggar W.E., Good R.A. Paucity of thymus-dependent cells in human marrow. Transplantation 1972, 14:284-286.
10. Speck B., Gluckman E., Haak H.L., et al. Treatment of aplastic anaemia by antilymphocyte globulin with or without marrow infusion. Clin Haematol 1978, 7:611-621.
11. Parkman R., Rappeport J., Geha R., et al. Complete correction of the Wiskott-Aldrich syndrome by allogeneic bone marrow transplantation. N Engl J Med 1978, 209:921-927.
12. Maris M.B., Niederwieser D., Sandmaier B.M., et al. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies. Blood 2003, 102:2021-2030.
13. Vossen J.M., de Koning J., van Bekkum D.W., et al. Successful treatment of an infant with severe combined immunodeficiency by transplantation of bone marrow cells from an uncle. Clin Exp Immunol 1973, 13:9-20.
14. Beatty P.G., Clift R.A., Mickelson E.M., et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 1985, 313:765-771.
15. Yunis E.J., Good R.A., Smith J., et al. Protection of lethally irradiated mice by spleen cells from neonatally thymectomized mice. Proc Natl Acad Sci U S A 1974, 71(6):2544-2548.
16. Zinkernagel R.M. Thymus function and reconstitution of immunodeficiency. N Engl J Med 1978, 198:222.
17. Keightley R., Lawton A.R., Cooper M.D. Successful fetal liver transplantation in a child with severe combined immunodeficiency. Lancet 1975, 2:850-853.
18. Buckley R.H., Whisnant J.K., Schiff R.I., et al. Correction of severe combined immunodeficiency by fetal liver cells. N Engl J Med 1976, 297:1076-1081.
19. O'Reilly R.J., Kapoor N., Kirkpatrick D. Fetal tissue transplants for severe combined immunodeficiency- their limitations and functional potential. Primary immunodeficiencies INSERM symposium No. 16 1980, 419-433. Elsevier, N Holland (Dutch). M. Seligmann, W.H. Hitzig (Eds.).
20. O'Reilly J., Pollack M.S., Kapoor N., et al. Fetal liver transplantation in man and animals. Recent advances in bone marrow transplantation. UCLA symposia on molecular and cellular biology 1983, vol. 7:799. Alan R. Liss, Inc, New York. R.P. Gale (Ed.).
21. Mebius R.E., Miyamoto T., Christensen J., et al. The fetal liver counterpart of adult common lymphoid progenitors gives rise to all lymphoid lineages, CD45+CD4+CD3- cells, as well as macrophages. J Immunol 2001, 166:6593-6601.
22. Boehmer H., Sprent J., Nabholz M. Tolerance to histocompatibility determinants in tetraparental bone marrow chimeras. J Exp Med 1975, 141(2):322-334.
23. Reisner Y., Kapoor N., Kirkpatrick D., et al. Transplantation for acute leukemia with HLA-A and -B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red cells. Lancet 1981, 2:327-331.
24. Papadopoulos E.B., Carabasi M.H., Castro-Malaspina H., et al. T-cell-depleted allogeneic bone marrow transplantation as postremission therapy for acute myelogenous leukemia: freedom from relapse in the absence of graft-versus-host disease. Blood 1998, 91:1083-1090.
25. Flake A.W., Zanjani E.D. In utero transplantation for thalassemia. Ann N Y Acad Sci 1998, 850:300-311.
26. Carr M.C., Stites D.P., Fudenberg H.H. Dissociation of responses to phytohaemagglutinin and adult allogeneic lymphocytes in human foetal lymphoid tissues. Nature New Biol 1973, 241(113):279-281.
27. Flake A.W., Roncarolo M.-G., Puck J.M., et al. Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med 1996, 335:1806-1810.
28. Wengler G.S., Lanfranchi A., Frusca T., et al. In-utero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDXI). Lancet 1996, 348:1484-1488.
29. Bambach B.J., Moser H.W., Blakemore K., et al. Engraftment following in utero bone marrow transplantation for globoid cell leukodystrophy. Bone Marrow Transplant 1997, 19:399-402.
30. Kantoff P.W., Kohn D.B., Mitsuya H., et al. Correction of adenosine deaminase deficiency in cultured human T and B cells by retrovirus-mediated gene transfer. Proc Natl Acad Sci U S A 1986, 83:6563-6567.
31. Blaese R.M., Culver K.W., Miller A.D., et al. T lymphocyte-directed gene therapy for ADA-SCID: initial trial results after 4 years. Science 1995, 270:475-480.
32. Hacein-Bey-Abina S., Le Deist F., Carlier F., et al. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 2002, 346:1185-1193.
33. Hacein-Bey-Abina S., von Kalle C., Schmidt M., et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2003, 348:255-256.
34. Aiuti A., Slavin S., Aker M., et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 2002, 296:2410-2413.
35. Bach F.H., Alberini R.J., Anderson J.L., et al. Bone marrow transplantation in a patient with the Wiskott-Aldrich syndrome. Lancet 1968, 2:1364-1366.
36. O'Reilly R.J., Keever C.A., Small T.N., et al. The use of HLA non-identical T-cell depleted marrow transplants for correction of severe combined immunodeficiency. Immunodefic Rev 1989, 1:273-309.
37. Patel D.D., Gooding M.E., Parrott R.E., et al. Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 2000, 342:1325-1332.
38. Neven B., Leroy S., Decaluwe H., et al. Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency. Blood 2009, 113:4114-4124.
39. Pollack M.S., Kirkpatrick D., Kapoor N., et al. Identification by HLA typing of intrauterine-derived maternal immunodeficiency. N Engl J Med 1982, 307:662-666.
40. Rosenkrantz K., Keever C., Bhimani K., et al. Both ongoing suppression and clonal elimination contribute to graft-host tolerance after transplantation of HLA mismatched T cell-depleted marrow for severe combined immunodeficiency. J Immunol 1990, 144:1721-1728.
41. Bacchetta R., Bigler M., Touraine J.L., et al. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med 1994, 179:493-502.
42. Roncarolo M.G., Yssel H., Touraine J.L., et al. Antigen recognition by MHC-incompatible cells of a human mismatched chimera. J Exp Med 1988, 168(6):2139-2152.
43. Geha R.S., Rosen F.S. The evolution of MHC restrictions in antigen recognition by T cells in a haploidentical bone marrow transplant recipient. J Immunol 1989, 143:84-88.